Pricing

Xenetic Biosciences Inc (XBIO)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Jeffrey F. Eisenberg
Employees:
4
945 CONCORD ST., FRAMINGHAM, MA, 01701
781-778-7720
    Formally known as:
  • GENERAL AIRCRAFT INC COMMON STOCK
  • XENETIC BIOSCIENCES INC NEW COM STK
Stock Split History
DateRatio
2019-06-25 1:12
2023-05-15 1:10
Xenetic Biosciences, Inc. focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology. The company has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available